High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease

Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).(1) Patients with IBD historically have had low vaccine uptake relative to the general population.(2) However, a recent survey suggested a rate higher than that of the general populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schell, Trevor L., Richard, Luke J., Tippins, Katharine, Russ, Rachel K., Hayney, Mary S., Caldera, Freddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654458/
https://www.ncbi.nlm.nih.gov/pubmed/34896281
http://dx.doi.org/10.1016/j.cgh.2021.12.013
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).(1) Patients with IBD historically have had low vaccine uptake relative to the general population.(2) However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor’s degree or higher level of education.(3) Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.(4,5)

Ejemplares similares